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[Abstract] 
Background. A malpositioned heart with apicocaval juxtaposition may complicate the management of patients 
with functional single ventricles when total cavopulmonary connection is performed. We reviewed our 
experience with extracardiac total cavopulmonary connection in patients with apicocaval juxtaposition with a 
special focus on route selection and outcomes.   
Methods. Out of 68 patients who underwent extracardiac total cavopulmonary connection at our hospitals, 10 
patients with apicocaval juxtaposition were included in this study. The mean follow-up was 40 ± 28 months. 
Patient demographics were compared with data on patients without apicocaval juxtaposition.  
Results. The age at operation was 8 ± 7 years. We carefully chose conduit routes to create satisfactory fluid 
dynamics. The conduit was placed between the inferior vena cava and the ipsilateral pulmonary artery in 2 
patients, and the conduit crossed midline in 8. The mean postoperative pulmonary artery pressure was 13 ± 2 
mmHg. The surgical and postoperative data were not significantly different when compared with the patients 
without apicocaval juxtaposition. There were no conduit-related early or late complications except for one 
patient who had poor ventricular function. 
Conclusions. Extracardiac total cavopulmonary connection in apicocaval juxtaposition can be carried out with 
favorable mid-term outcomes. The route between the inferior vena cava and the contralateral pulmonary artery 
should be the primary choice when the relevant pulmonary artery is in good shape. Care must be taken in 
regard to critical conduit oppression by the ventricle in cases with large ventricular volume and/or poor 
ventricular function. 
(243 words) 
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Since extracardiac total cavopulmonary connection (EC-TCPC) was first introduced as a definitive 
procedure for patients with functionally univentricular heart in 1990 [1], many surgeons have adopted this 
approach as their procedure of choice for the Fontan completion. It has been well established that EC-TCPC 
has potential advantages over lateral tunnel-type connection. It makes it possible to avoid aortic 
cross-clamping and atriotomy, therefore allowing for a shorter duration of cardiopulmonary bypass (CPB). 
Near-optimal laminar flow in the systemic venous pathway means no atrial stretch or arrhythmia in the 
long-term, although the prosthetic conduit lacks growth potential and patients may be obliged to have lifelong 
prophylactic anticoagulant therapy [2-4]. 
In a malpositioned univentricular heart with apicocaval juxtaposition (ACJ), however, the completion of 
EC-TCPC may be compromised by difficulty in securing an appropriate conduit pathway. When the conduit is 
positioned behind the apex toward the ipsilateral pulmonary artery (PA), obstruction of the conduit or 
oppression either on the pulmonary veins, atrium or ventricle is of concern because of the narrow space. On 
the other hand, when the conduit crosses the midline toward the contralateral PA, a long curved conduit route 
may cause a kink or serious energy loss.  
Little is known about the outcome of the EC-TCPC for ACJ because of the rare morphological features of 
this alignment. Only one recent clinical investigation has focused on this issue [5] and several others are case 
or technical reports [6-9]. We therefore set out to examine our experience with EC-TCPC in ACJ and shed 
some light on the factors which influence the decision on route choice. 
 
Patients and Methods 
Patients 
Between 2001 and 2011, 68 patients underwent EC-TCPC at our two pediatric centers (University of 
Tsukuba Hospital and Ibaraki Children’s Hospital) following the same management policy. Among them, we 
retrospectively reviewed the medical records of 10 patients with functional single ventricle and ACJ. Charts 
were examined for patient demographics including age, weight, diagnosis, conduit route, conduit size, pre- 
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and postoperative hemodynamic data, additional cardiac operations, and operative details. Endpoints included 
take down, thromboembolic events and death. These data were compared with the data of 58 patients without 
ACJ. The study was approved by the Institutional Review Board at University of Tsukuba Hospital and 
Ibaraki Children’s Hospital, and individual consent for the study was waived owing to its retrospective 
medical record review design. 
 
Operative Technique 
Based on a careful preoperative evaluation, we chose a conduit route to create the most appropriate 
cephalad (conduit to the PA) anastomosis which would provide satisfactory fluid dynamics for Fontan 
circulation. After re-do median sternotomy, dissection around the heart was carefully performed. CPB was 
established with direct bicaval cannulation. The heart was arrested by aortic cross clamping with cold 
crystalloid cardioplegia infusion through the aortic root when intracardiac manipulation such as the creation of 
an atrial septal defect, valve repair or main PA division was required. Otherwise an extracardiac conduit 
(Gore-Tex®, Stretch Vascular Graft) was anastomosed with the caudal surface of either the right or left PA on 
the beating heart. In 2 patients the extracardiac conduit was placed between the inferior vena cava (IVC) and 
the ipsilateral PA behind the ventricle to create the shortest route. In the 8 other patients the conduit was 
placed between the IVC and the contralateral PA taking a slightly roundabout route. After extensive dissection 
and mobilization of the IVC at the diaphragmatic level, the caudal end of the conduit was sutured to the 
transected IVC in an end-to-end fashion. A fenestration was created only in patient No.8 who had a dilated 
ventricle with poor function. 
 
Postoperative Evaluation  
A routine postoperative evaluation was made by echocardiography, cineangiography and cardiac 
catheterization about 1 month after surgery and postoperative PA pressure was measured. Some patients 
underwent cardiac catheterization about 1 year after surgery, but this is not routine. Computed tomography 
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(CT) was performed only when follow-up physicians requested it for evaluation.   
 
Anticoagulation 
Anticoagulation therapy with intravenous heparin infusion (200 U/kg/day) was initiated within 12 hours 
after surgery when hemostasis was secured. Subsequently heparin was replaced by warfarin sodium as soon as 
the patients resumed oral intake. Thereafter the international normalized ratio of prothrombin time was 
maintained at 1.5-2.5.  
 
Statistical Analysis 
All of the patients’ data were reviewed retrospectively from the database of the University of Tsukuba 
Hospital and Ibaraki Children’s Hospital. Quantitative data are presented as mean ± standard deviation. 
Comparisons between the two groups were performed with an unpaired two-tailed t-test for normally 
distributed variables. Statistical significance was considered at p values less than 0.05.  
 
Results 
Patient Characteristics 
The characteristics of the patients with ACJ are listed in Table 1. The diagnoses of these patients 
included the heterotaxy syndrome (n = 4, right isomerism in 3 cases, left isomerism in 1), right ventricular 
type univentricular heart (n = 1), double outlet right ventricle (n = 2), double inlet left ventricle (n = 1), and 
univentricular heart with indefinite ventricular type (n = 2). The mean age at operation was 8 ± 7 years (range, 
3 - 24), and the mean body weight was 22.1 ± 14.8 kg (range, 11.5 - 57.5). Preoperative cardiac 
catheterization showed adequate hemodynamic data for Fontan-type repair, with Nakata-index of 272 ± 160 
mm2/m2 (range, 117 - 636) and a mean PA pressure of 11 ± 4 mmHg (range, 6 – 18). All 10 patients 
underwent bidirectional cavopulmonary connection before EC-TCPC based on a staged Fontan strategy. 
There was no significant difference in the preoperative patient characteristics when compared with the 58 
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patients without ACJ (Table 2).  
 
Surgical Outcomes 
In the patients with ACJ, the mean CPB time was 196 ± 67 minutes (range, 111 - 349 minutes). The 
heart was arrested only when intracardiac manipulation was required. The diameter of the extracardiac conduit 
was 16 mm in 1 patient, 18 mm in 8 patients, and 20 mm in 1 patient. The mean postoperative PA pressure 
was 13 ± 2 mmHg (range, 11 - 20 mmHg, including the last data on patient No. 8). The median duration of 
intensive care unit stay was 6 days. The mean follow-up was 40 ± 28 months (range, 2 - 71 months). These 
surgical and postoperative data were not significantly different when compared with the patients without ACJ 
(Table 2). There was no conduit-related reoperation in any patient expect for 1 in whom acute conduit 
occlusion developed. Postoperative cineangiogram (Fig 1) and CT (Fig 2) showed a curved but unobstructed 
venous pathway when the conduit was placed between the IVC and the contralateral PA. On the other hand, in 
a case in which the conduit was positioned behind the apex, CT showed no conduit obstruction or oppression 
either on the pulmonary veins or ventricle, although slight compression on the atrium was seen (Fig 3). 
One young adult patient with double outlet of right ventricle (No.8) developed acute thrombotic 
occlusion of the conduit on the 8th postoperative day. Despite efforts with surgical thrombectomy and 
thrombolysis, the patient died due to bleeding and multiple organ dysfunctions within 48 hours. Since the 
patient had a large and poorly functioning single right ventricle (ejection fraction 41%, diastolic diameter 
65mm), an extracardiac TCPC was selected instead of an intracardiac tunnel to avoid cardiac arrest, and a 
fenestrated conduit was placed between the IVC and the contralateral PA so as to avoid compression behind 
the enlarged ventricle. Still, the conduit was constricted between the bottom of the enlarged ventricle and the 
diaphragm. Among the 67 other TCPC cases, none of the patients experienced early or late death, conduit 
stenosis or pulmonary venous obstruction.  
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Comments 
Our experience shows favorable clinical EC-TCPC outcomes in patients with functional single ventricle 
and ACJ. Nine of 10 patients tolerated EC-TCPC without early mortality, re-exploration, take down or 
significant morbidity. Either conduit route could be conducted without external compression, pulmonary 
venous obstruction or thromboembolic event. 
Based on our experience, the route between the IVC and the contralateral PA should take precedence over 
the route behind the ventricle since a space for the conduit placement can be easily secured without flipping 
over the ventricle or extensive dissection. The biggest concern in this design is a relatively longer and curved 
conduit which crosses the midline toward the contralateral PA and may therefore lead to a certain amount of 
energy loss. However, no excessive venous resistance, kinks or thromboembolic events were encountered in 
this roundabout route in the standard risk cases. We do not think that conduit oppression by the spine is a 
serious matter because the IVC usually locates anterior to the spine in normal anatomy and even in heterotaxy 
(Fig 2). Probably the most important factor in choosing the conduit route is the facility in making a 
satisfactory cephalad anastomosis which provides better fluid dynamics in Fontan circulation. If one of the 
PAs is good in size without severe adhesion, calcification or previous stenting, and can be exposed widely 
against the aorta, it is preferable as a site for cephalad anastomosis. The need for pulmonary augmentation can 
be another inevitable reason in selecting the anastomotic site. A conduit can then be conducted towards the 
IVC in either way. When both PAs are in equal condition, although route choice depends on space availability 
and severity of adhesion, it is quite rational to choose the route between the IVC and the contralateral PA with 
minimal dissection. In this setting, a fenestration can be easily created even after cessation of CPB since the 
conduit and the atrium are adjacent to each other.  
The reasons we chose the route behind the ventricle as exceptions in two of our cases are as follows. In 
case No.5, there was tight adhesion and calcification at the right PA (contralateral to the IVC) after repeated 
surgical manipulations in previous PA plasty procedures. In case No.6, the right PA (contralateral to the IVC) 
was a little smaller than the opposite PA and angled off toward the posterior. In addition, since the enlarged 
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ascending aorta was overlying the right PA, it was better to secure a cephalad anastomosis onto the left PA. In 
both cases, conduit space behind the atrium and ventricle was relaxed by opening the pleural cavity. 
Maximum efforts were made to avoid pulmonary venous obstruction by aggressive dissection around the 
pulmonary veins.  
In adult patients with dilated ventricles with poor function as in our case No. 8, a conduit route should be 
created very carefully [10, 11]. Our choice was not successful since the space between the bottom of the 
enlarged ventricle and the diaphragm was probably too narrow and therefore the long conduit was compressed 
and inevitably had a nearly right-angled curve around the IVC anastomotic site. With such conditions, an 
intraatrial tunnel could be an alternative but such a complex procedure requires aortic cross clamping and 
cardiac arrest, and therefore may deteriorate ventricular function [12]. Kawahira and colleagues described a 
modified Fontan technique with a handmade shoetree extracardiac graft which gently bridged the vertebra in a 
patient with ACJ [8]. The technique may be effective in anastomosing the IVC orifice with the conduit 
without creating an obstructive venous pathway. 
In the literature, there are only a few reports which have addressed the issue of EC-TCPC in patients with 
ACJ. Surprisingly, these reports and several other case presentations have all come from Japan or South Korea 
[5-9]. It is well known that there is a higher incidence of heterotaxy in eastern Asia, but there may be a higher 
incidence of ACJ as well. Previous reports have not clearly mentioned how to decide upon an appropriate 
conduit route, although Sakurai and colleagues showed that there was no obvious superiority of the pathway 
behind the ventricle as compared with the pathway crossing the spine. They pointed out that the condition of 
the anastomotic site, dimension of the apex and need for pulmonary augmentation are important factors in 
selecting the pathway [5]. In the present report, we clearly state that the route between the IVC and the 
contralateral PA should be the primary choice as far as there is no concern about PA size and condition since 
the route is less invasive and technically beneficial.  
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Study Limitations  
This is a retrospective, observational study. Although all patients had clear documentation of pre- and 
postoperative variables, other interesting variables such as pulmonary vascular resistance and dimension of 
the atrium or ventricle were less well documented and could not be examined in relation to the outcome. As 
the study covered more than 25 years of experience since first palliation, older patients could be treated on the 
palliation policy in the early surgical era. Moreover, since the number of ACJ patients for each conduit 
pathway was small, comparative analyses with regard to outcome for each group could not been performed. 
In conclusion, EC-TCPC for patients with functional single ventricle and ACJ can be carried out with 
favorable mid-term outcomes. The route between the IVC and the contralateral PA should be the primary 
choice if the PA is in good shape. Care must be taken regarding critical conduit oppression by the ventricle in 
cases with large ventricular volume and/or poor ventricular function.  
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Table 1. Patients' Characteristics, and Pre-, Intra and Postoperative Data in Apicocaval Juxtaposition                
No. Diagnosis Age Weight PAI Preop mPAP Conduit Route CPB AXC Fenestration Postop mPAP Follow Up Adverse Event Prognosis  
    (year) (kg)  (mm2/m2) (mmHg) (mm)   (min) (min)   (mmHg) (month)      
                
1 SV, PA, Dextrocardia 6 16.7 131 15 18 Contra 208 27 - 16 71 - Alive  
                
2 SV, PA, Situs Inversus 3 14.8 158 10 18 Contra 166 - - 11 69 - Alive  
                
3 DORV, PS, Situs Inversus 4 13.2 117 14 18 Contra 241 38 - 11 58 - Alive  
                
4 SV, PS, Asplenia 3 16.5 175 18 18 Contra 234 113 - 12 57 - Alive  
                
5 RV type SV, PA, Situs Inversus 15 37.7 296 10 18 Ipsi 156 - - 15 63 - Alive  
                
6 Hypoplastic LV, AVSD, TOF 5 13.2 254 11 18 Ipsi 148 69 - 15 18 - Alive  
 Polysplenia               
7 SV, PS, Asplenia, Dextrocardia 12 26.5 636 7 18 Contra 111 44 - 13 12 - Alive  
 TAPVC Ia               
8 DORV, TA, PS, Dextrocardia 24 57.5 314 6 20 Contra 349 - + (20)  - 
Conduit 
Occlusion 
Dead  
                
9 DILV, PS 5 11.5 207 8 16 Contra 167 35 - 14 10 - Alive  
                
10 SV, PS, Asplenia, Dextrocardia 5 13.7 429 14 18 Contra 157 69 - 14 2 - Alive  
  TAPVC III                            
AVSD = atrioventricular septal defect;  AXC = aortic cross clamp;  Contra = IVC-contralateral PA route;  DILV = double inlet left ventricle;  DORV = double outlet right ventricle;   
Ipsi = IVC-ipsilateral PA route;  mPAP = mean pulmonary artery pressure;  PA = pulmonary atresia;  PAI = pulmonary artery index (Nakata index);  PS = pulmonary stenosis;  SV = single ventricle; 
TA = tricuspid atresia;  TAPVC = total anomalous of pulmonary venous connection;  TOF = tetralogy of Fallot 
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Table 2. Comparison of Two Groups Regarding Pre-, Intra- and Postoperative Data  
 Patients with ACJ Patients without ACJ p Value  
  (n = 10) (n = 58)    
     
Age (year) 8 ± 7 5 ± 4 0.17  
     
Body Weight (kg) 22.1 ± 14.8 18.4 ± 7.5 0.28  
     
PAI (mm2/m2) 272 ± 160 286 ± 135 0.57  
     
Preoperative mPAP (mmHg) 11 ± 4 11 ± 5 0.76  
     
CPB time (minute) 196 ± 67 166 ± 52 0.31  
     
Diameter of Conduit     
16mm 1 6   
18mm 8 51   
20mm 1 1   
     
Fenestration 1 (No. 8) 4   
     
Postoperative mPAP (mmHg) 13 ± 2 14 ± 3 0.21  
     
ICU Stay (day) 6 ± 2 5 ± 3 0.46  
     
Follow Up (month) 40 ± 28 54 ± 33  0.13  
     
Adverse Event     
Thrombosis 1 (No. 8) 0   
Death 1 (No. 8) 0   
         
ACJ = apicocaval juxtaposition;  CPB = cardiopulmonary bypass;  
ICU = intensive care unit;  mPAP = mean pulmonary artery pressure; 
PAI = pulmonary artery index (Nakata index) 
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Figure Legends 
 
Fig 1. Cineangiogram of the extracardiac conduit shows a curved and unobstructed venous pathway in the inferior 
vena cava to the contralateral pulmonary artery route in a patient with apicocaval juxtaposition.  
 
Fig 2. Computed tomography image of the extracardiac conduit placed between the inferior vena cava (IVC) and the 
contralateral pulmonary artery in an asplenia patient with apicocaval juxtaposition (patient No. 10, Two months after 
surgery). (A to D) Four levels from the cephalad anastomosis to the IVC. The conduit crosses midline but is not 
oppressed by the spine since the IVC locates anterior to the spine. (A = atrium; C = conduit; PA = pulmonary artery; 
PV = pulmonary vein; V = ventricle) 
 
Fig 3. Computed tomography image of the extracardiac conduit placed between the inferior vena cava (IVC) and the 
ipsilateral pulmonary artery in a patient with apicocaval juxtaposition (patient No. 5, Seven years after surgery). (A, 
B) Cephalad portion of the conduit locates between the atrium and the pulmonary veins. The conduit slightly presses 
the atrium but not the pulmonary veins. (C, D) Caudal portion of the conduit near the IVC. The conduit has no contact 
with the ventricle throughout the route. (A = atrium; C = conduit; PV = pulmonary vein; V = ventricle) 
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Figure 1 
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Figure 2 
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Figure 3 
 
